Le Lézard
Classified in: Business
Subject: ATY

VRX Investor Alert: Kyros Law is Investigating Legal Claims on Behalf of Valeant Pharmaceuticals Intl (NYSE: VRX) Investors

BOSTON, Oct. 5, 2017 /PRNewswire/ -- Kyros Law Offices is alerting investors of Valeant Pharmaceuticals Intl (NYSE: VRX)  that it is investigating legal claims against the company for possible securities fraud violations committed by Valeant Pharmaceuticals Intl (NYSE: VRX).

Valeant Pharmaceuticals Intl (NYSE: VRX)  investors that have invested over $100,000 before March 2016 are urged to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to speak to someone about your case.

The investigation concerns possible violations of securities law committed by Valeant Pharmaceuticals Intl (NYSE: VRX)  management that has led to significant losses to investors. Recent lawsuits filed against the company allege that Valeant Pharmaceuticals Intl (NYSE: VRX)  may have improperly used a pharmacy network to artificially increase sales for their drugs.

In February 2016, Valeant Pharmaceuticals Intl (NYSE: VRX) announced it would restate its financial results, citing issues with revenue recognition stemming from sales from a specific pharmacy network. That same month, the company came under SEC investigation. During this time, the stock price of VRX dropped significantly, with the share prices dropping more than 90%.

Kyros Law has been recently contacted by numerous unhappy VRX investors with hundreds of thousands of dollars invested in the company. The law firm is dedicated to fighting for the rights of these investors, and other investors that have lost money in VRX stock.

Kyros Law Offices urges Valeant Pharmaceuticals Intl (NYSE: VRX)  investors that invested more than $100,000 prior to March 2016 to contact our law firm immediately to protect their rights. Visit our VRX Lawsuit website or call 1-800-934-2921 to find out if you have a case.

Kyros Law specializes in a wide range of complex litigation, mass torts, and corporate governance matters, including the representation of whistleblowers, shareholders and consumers in securities fraud, false claims act and class actions. Our lawyers have been responsible for recovering hundreds of millions of dollars for our clients throughout the United States, Africa, Asia and Europe. Visit our website to learn more about our firm.

SOURCE Kyros Law

These press releases may also interest you

at 18:30
Enterprise Group, Inc. ("Enterprise," or "the Company") announces the voting results of its annual and special meeting of shareholders held on June 21, 2018. The detailed results of the vote are set out below. Election of Directors The following...

at 18:00
Alimentation Couche-Tard Inc. ("Couche-Tard") , will be holding a conference call on July 10th, 2018, at 8:00 A.M. (EDT) to present its fourth quarter and  fiscal 2018 financial results. As such, Brian Hannasch, President and CEO, as well as Claude...

at 17:58
Pamela J. Berry is recognized by Continental Who's Who as a Platinum Lifetime Member in the field of Office Management in recognition of her role as Office Manager of Michael P. Mullen, CPA, PLLC.     Located in Minneapolis, Minnesota, Michael P....

at 17:46
The Office of the Secretary issued a Notice of Hearing setting the matter down to be heard on July 3, 2018 at 10:00 a.m. to consider an Application for Extension of Temporary Order in the above named matter. A copy of the Notice of Hearing dated...

at 17:33
Nasdaq today announced the Nasdaq Closing Cross had a record day as it was used for the 15th consecutive year to rebalance Nasdaq-listed securities in the entire family of Russell U.S. Indexes, part of leading global index provider FTSE Russell,...

at 17:30
Canopy Health's expansion into the South Bay has been officially approved by the Department of Managed Health Care (DMHC). The unique, high-performance network is growing its pioneering healthcare model by adding two medical groups and three...

News published on 5 october 2017 at 19:46 and distributed by: